The Patent Finder

SIGA Pharmaceuticals, Inc.

Also on record
Records under this name other than patents SIGA Pharmaceuticals, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.

Back to SIGA Pharmaceuticals, Inc.

PatentTitleStatus Expires Confidence
US 6,872,542Treatment or prophylaxis of diseases caused by pilus-forming bacteria
Lapsed on the fee record
Ended Mar 29, 2013 · From the USPTO record
Lapsed on the fee recordEnded Mar 29, 2013From the USPTO record
US 6,153,396Treatment or prophylaxis of diseases caused by pilus-forming bacteria
Formerly held
Lapsed on the fee record
Ended Nov 28, 2012 · From the USPTO record
Lapsed on the fee recordEnded Nov 28, 2012From the USPTO record
US 6,596,504Treatment of prophylaxis of diseases caused by pilus-forming bacteria
Lapsed on the fee record
Ended Jul 22, 2011 · From the USPTO record
Lapsed on the fee recordEnded Jul 22, 2011From the USPTO record
US 6,548,265Treatment or prophylaxis of diseases caused by pilus-forming bacteria
Lapsed on the fee record
Ended Apr 15, 2011 · From the USPTO record
Lapsed on the fee recordEnded Apr 15, 2011From the USPTO record
US 6,420,127Compounds and pharmaceutical compositions for the treatment and prophylaxis of bacterial infections
Formerly held
Lapsed on the fee record
Ended Jul 16, 2010 · From the USPTO record
Lapsed on the fee recordEnded Jul 16, 2010From the USPTO record
US 7,025,971Treatment or prophylaxis of diseases caused by pilus-forming bacteria
Lapsed on the fee record
Ended Apr 11, 2010 · From the USPTO record
Lapsed on the fee recordEnded Apr 11, 2010From the USPTO record
US 6,962,791Treatment or prophylaxis of diseases caused by pilus-forming bacteria
Lapsed on the fee record
Ended Nov 8, 2009 · From the USPTO record
Lapsed on the fee recordEnded Nov 8, 2009From the USPTO record
US 6,312,955Streptococcus gordonii strains resistant to fluorodeoxyuridine
Lapsed on the fee record
Ended Nov 6, 2009 · From the USPTO record
Lapsed on the fee recordEnded Nov 6, 2009From the USPTO record
US 6,306,619DegP periplasmic protease a new anti-infective target and an in vitro assay for DegP protease function
Lapsed on the fee record
Ended Oct 23, 2009 · From the USPTO record
Lapsed on the fee recordEnded Oct 23, 2009From the USPTO record
US 5,821,088Use of gram-positive bacteria to express recombinant proteins
Formerly held
Term ended
Term ended no later than Oct 13, 2018 · Low confidence
Term endedTerm ended no later than Oct 13, 2018Low confidence
10 of 13 patents shown.
Pro members see all 13.
Pro members: see all 13 patents
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited